Eiger BioPharmaceuticals to Participate in Two Investor Conferences in November 2016
- 2016 Oppenheimer Life Sciences Summit,
Sofitel Hotel ,New York City ,November 29, 2016 , individual meeting format Piper Jaffray 28th Annual Healthcare Conference,Lotte New York Palace Hotel ,New York City ,November 30, 2016 ,12:30 pm ET , "Fireside Chat" format
A live webcast of the
About Eiger
Eiger is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare diseases. The company has built a diverse portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which an effective therapy is urgently needed. For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
Investors:
Logo - http://photos.prnewswire.com/prnh/20151108/285009LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-participate-in-two-investor-conferences-in-november-2016-300366436.html
SOURCE